Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02442973 · ClinicalTrials.gov registry record
Handheld 3D Lumbar Spine Navigation: A Clinical Validation Study RM002
A clinical trial, sponsored by University of Virginia.
- Completed
- Registry status
- 130
- Enrollment target
NCT02442973: Completed study, sponsored by University of Virginia.
NCT02442973 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 130 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02442973 has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 130 participants
- Enrollment target
Study Summary
Currently, at UVA, handheld ultrasound devices (like those used to view an unborn baby) are only two dimensional. The Accuro is a three dimensional handheld ultrasound device. This device uses sound waves to create pictures of the spine in three dimensions. This may allow the physician to view the spine in more detail for procedures such as spinal anesthesia and other diagnostic procedures. Epidural analgesia is the mainstay procedure for the management of labor pain. The precise placement of a needle or catheter in proximity to landmarks of the spinal bone anatomy is required for the procedure to succeed. The current standard of care is called the 'blind approach' (i.e. without medical imaging) and involves a physician manually palpating a patient's back to locate spinal bone landmarks. The needle is then inserted with respect to the location of the landmarks and inserted until a loss-of-resistance is manually detected. This approach, while most common, has been associated with success rates as low as 68% in obese patients (2). Alternative methods have been investigated for this problem, including ultrasound (US) guidance, which offers real-time imaging. Several studies have demonstrated ultrasound's efficacy for spinal anesthesia (1-6). However, standard US systems are engineered to image soft tissue rather than bone structures, with the consequence that bone is imaged poorly. US images are often degraded by a number of noise sources including speckle noise, reverberations and off-axis scattering, particularly when bone is present, making visualization of bone anatomy features difficult. Moreover, arranging access to ultrasound for the purpose of spinal anesthesia alone is cumbersome. Thus, the efficacy of guided spinal anesthesia and diagnostic procedures using standard ultrasound systems is limited and the benefits that it offers are heavily dependent on the user's familiarity and skill with ultrasonography (4). Recently, new medical imaging technologies have
Primary Outcome
defined as successful epidural administration on the first needle insertion attempt.
Interventions
- PROCEDURE Control group (CG): standard practice
- PROCEDURE Ultrasound group (UG):
- DEVICE Accuro SpineView3D™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2016-02 |
| Est. Completion | 2018-01-12 |
What the finished NCT02442973 record still lists
NCT02442973 is an observational study that tracks outcomes without assigning an intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Control group (CG): standard practice is the first listed.
NCT02442973 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02442973 about?
NCT02442973 is a clinical study titled "Handheld 3D Lumbar Spine Navigation: A Clinical Validation Study RM002". Currently, at UVA, handheld ultrasound devices (like those used to view an unborn baby) are only two dimensional. The Accuro is a three dimensional handheld ultrasound device. This device uses sound waves to create pictures of the spine in three dimensions. This may allow the physician to view the s...
What is the current status of trial NCT02442973?
This trial is currently completed. The enrollment target is 130 participants. The study started on 2016-02. Estimated completion is 2018-01-12.
What interventions are being tested in trial NCT02442973?
The interventions under investigation include: Control group (CG): standard practice (PROCEDURE), Ultrasound group (UG): (PROCEDURE), Accuro SpineView3D™ (DEVICE).
Who is sponsoring clinical trial NCT02442973?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia